Global
Mendelian disorder testing Market -
Overview
The
Mendelian disorder is genetic disorder in humans which arises due to mutation
in a single gene. Mendelian disorder can be predicted with the help of a
genograms. Hemophilia, thalassemia, color blindness, cystic fibrosis, sickle
cell anemia,and phenylketonuria are the most common mendeliandisorders.
Mendelian disorder is of four typesautosomal dominant, autosomal
recessive, sex-linked dominant and sex-linked recessive. Genetic testing allows
diagnosis of inherited diseases, it determines the changes in chromosomes,
genes, proteins and metabolites. Some of the available genetic tests are: cell
free foetal DNA testing, new-bornscreening, prenatal diagnosis, carrier
testing, preimplantation genetic diagnosis, predictive and presymptomatic
testing.
Get
a Free Sample
@ https://www.marketresearchfuture.com/sample_request/5500
Globally
Mendelian Disorders Testing Market Growth is estimated to
grow at a rate of 6.5% during the forecast period.
The
market is going to continue with the same trends of growth during the forecast
period2017-2023. According to U.S. Department of Health and Human Services, there
are 70,000 to 80000 Americans affected by sickle cell disease,an inherited
blood disorder. Thousands of new-borns are detected with beta thalassemia
each year. Beta thalassemia is normallyaffects people from Central Asia,
the Middle East, India,Southeast Asia, Mediterranean countries, and North Africa.Cystic
fibrosis,a genetic disease occurs in 1 in 2,500 to 3,500 US new-borns. Therefore,
the major factor driving the growth of the market is increasing prevalence of mendeliandiseases.
Other factor include increasing technology advancement in genetic testing,
increasing awareness in emerging economies for genetic testing, increasing simple,
accessible procedureand various others.
Whereas,
cost required for developing technology and inaccurate results may hinderthe
growth of the market.
Key Players:
Some of key the
players in the global mendelian disorders testing market are Bio-Rad
Laboratories, Inc. (U.S.),Transgenomic Inc. (U.S.), ELITechGroup (France),
Quest Diagnostics (U.S.), AutoGenomics (U.S.), Abbott Laboratories
(U.S.),PerkinElmer Inc. (U.S.), Celera Group (U.S.), Roche Diagnostics (Switzerland),
Applied Biosystems Inc. (U.S.), Thermo Fisher Scientific and others.
Global
Mendelian disorder testing Market -
Competitive Analysis
There are many players of
the Mendelian disorder testing Market Growth but the existing players are strengthening their position
in the industry by innovating technically advanced products. With
well-established market, major companies like Abbott laboratories, ELITech Biomedical Systems,
Thermo Fisher Scientific, Myriad
Genetics Inc. and others acquire maximum market share.
Founded in 1900, Abbott
laboratories discovers, develops, and markets a series of healthcare products.
The company's Diagnostic Products include diagnostic systems and tests
manufactured, marketed, and sold worldwide. In August 2016, Abbott introducedAlinity,
a next-generation system used to carry out immunoassay, clinical chemistry,
hematology, blood and plasma screening and molecular diagnostics. With the
launch of Alinity portfolio, the company will be able to offer more efficiency
and flexibility to doctors and scientists and help them improve decision-making
and patient care.
ELITech Biomedical Systems
a well-known world leader for the diagnosis of cystic fibrosis.
ELITech’s Macroduct System is a simple and accurate sweat test system
available. The firm is involved in product innovation such as its research and
development department has developed Nanoduct, the miniature sweat
analysis system for patients of any age. This patented Nanoduct enables doctors
to intervene and treat this disease at an early stage. In April, 2018 ELITechGroup,
entered into an agreement with R-Biopharm, a life science company to strengthen
their positions in molecular infectious disease testing market.
Thermo Fisher Scientific an
American multinational biotechnology product development company, founded in
2006 by the merger of Thermo Electron and Fisher Scientific. In September,
2015, Thermo Fisher launched targeted sequencing system S5 and S5 XL systems. Thermo
Fisher concentrates on targeted sequencing applications in inherited disease,
oncology, reproductive health, infectious disease, and forensics. The S5 and S5
XL are research-use only products but in future Thermo Fisher plans to register
them with the US Food and Drug Administration. Along with the next generation
sequencing systems, Thermo Fisher also launched 13 targeted AmpliSeq panels comprising
3,000 Mendelian disease genes. Thus extending their product line.
Access
Full Report Details @ https://www.marketresearchfuture.com/reports/mendelian-disorders-testing-market-5500
Qiagen a leading provider
of molecular diagnostics is headquartered in Germany. QIAGEN announced new
GeneReader NGS chemistry is ready launch and can be used with QIAGEN’s Digital
NGS. Digital NGSuses Unique Molecular Index (UMI) technology that provides
accurate quantification and detection of molecular variants. This technology is
reliable and detects even the rarest of mutation. Thus fuelling its innovative
solutions for better results.
About Market Research
Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients. Our market research studies by products, services,
technologies, applications, end users, and market players for global, regional,
and country level market segments, enable our clients to see more, know more,
and do more, which help to answer all their most important questions.
In order to stay updated
with technology and work process of the industry, MRFR often plans &
conducts meet with the industry experts and industrial visits for its research
analyst members.
Contact
Akash
Anand,
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
+1
646 845 9312
No comments:
Post a Comment